Version 2.77

Descriptions

Moxifloxacin is a synthetic fluoroquinolone antibiotic agent. Bayer AG developed the drug (initially called BAY 12-8039) and it is marketed worldwide (as the hydrochloride) under the brand name Avelox® (in some countries also Avalox®) for oral treatment. Each tablet contains 400mg. In most countries the drug is also available in parenteral form for intravenous infusion. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Moxifloxacin (Wikipedia)

Moxifloxacin is a bacteriacidal fluoroquinolone antibiotic that is effective against gram-positive and gram-negative organisms as well as other infectious agents, including Mycobacterium tuberculosis. It is used to treat a broad range of infections, including pneumonia, multi-drug resistant tuberculosis, and endocarditis. Moxifloxacin increases the risk of tendinitis and tendon rupture, and is not recommended for children under the age of 18. [MedlinePlus Drug: a600002] Source: Regenstrief LOINC, MedlinePlus Drug: Moxifloxacin

Basic Part Properties

Part Display Name
Moxifloxacin
Part Type
Component (Describes the core component or analyte measured)
Created On
2002-01-10
Construct for LOINC Short Name
Moxifloxacin

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP28720-8
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP28720-8

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 莫西沙星
Synonyms: 喹诺酮类抗菌药;莫喜沙星
fr-CA French (Canada) Moxifloxacine
et-EE Estonian (Estonia) Moksifloksatsiin
es-ES Spanish (Spain) Moxifloxacino
it-IT Italian (Italy) Moxifloxacina
tr-TR Turkish (Turkey) Moksiflokzasin
ru-RU Russian (Russian Federation) Моксифлоксацин
nl-NL Dutch (Netherlands) moxifloxacine
fr-BE French (Belgium) Moxifloxacine